| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2017-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3f59ec31015400d02cf632e6325cf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75319cc58fe96388d3f84b8042e97bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26e34e7ab2e19ec80d6c796dd9374e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73b9eef418d50892cc2b2b15652c843f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3ec556de4eedbba9ae3c1504900029 |
| publicationDate |
2017-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017182495-A1 |
| titleOfInvention |
Indazole derivatives that down-regulate the estrogen receptor and possess anti-cancer activity |
| abstract |
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081857-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020058725-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020186250-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6993477-B2 |
| priorityDate |
2016-04-20^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |